LBx Summit 2024

SOPHiA GENETICS is excited to be part of the 8th Annual Liquid Biopsy for Precision Oncology Summit, held in person in San Diego, CA, USA, from February 28 to March 1, 2024.

You will have the chance to chat with our experts and learn more about our collaboration with AstraZeneca and Memorial Sloan Kettering Cancer Center (MSK) to decentralize their MSK-ACCESS® assay.

TALK
Access to Precision Oncology with Decentralized Liquid Biopsy Solutions

Talk, February 29
12-12:30 PM
Track B: Clinical Development & Commercialization

Liquid biopsy is emerging as a revolutionary technology, holding promise for swift and precise diagnostics. Despite the potential to positively impact precision oncology and the increasing popularity of NGS-based assays, liquid biopsy faces challenges, including workflow standardization across the globe, regulatory issues, guideline inclusion, and reimbursement hurdles.

Join us in this talk to hear about the SOPHiA GENETICS’ journey in expanding access to Liquid Biopsy at a global scale.

 

  • Understand the vital role of decentralizing liquid biopsy testing for early detection, patient identification, and treatment monitoring
  • Learn about SOPHiA DDM™ Liquid Biopsy (LBx) Solutions and the power of our decentralized and technology-agnostic SOPHiA DDM™ Platform
  • Hear about SOPHiA GENETICS’ collaboration with MSK and AstraZeneca, aiming to expand global access to advanced cancer testing and accessibility through MSK- ACCESS® powered by the SOPHiA DDM™ Platform

Presented by

T. Scott Reid, PhD 

VP & Global Head of Diagnostics

SOPHiA GENETICS

Event Date
February 28, 2024 – March 1, 2024

Event Type

In-person

Event Location

San Diego, US

Areas of Interest

Liquid Biopsy, BioPharma

Disclaimer notice:

The term SOPHIA used by the speaker refers to SOPHiA GENETICS and its products.

The opinions expresseda during this presentation are these of the speaker and may not represent the opinions of SOPHiA GENETICS.

SOPHiA GENETICS does not provide support in the validation of custom products for clinical use.

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.

pink dots icon

Want to know more?
Get in touch with us.

Our client services team is on hand to help.
';